Found 428 matching trials
Biomarkers Predictive for Cervical Intraepithelial Neoplasia Grade 2 (CIN2) Evolvement N/A Introduction Cervical intraepithelial neoplasia CIN1 (low grade), CIN2 (mod...
Show More Location
Department of Gynecology and Obstetrics, Herning Regional Hospital
Learn More & Join Trial
A Study of SY-1365 in Adult Patients With Advanced Solid Tumors PHASE1 This study consists of two parts. Part 1 is a dose-escalation/safety evalua...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Personalised Disease Monitoring in Metastatic Breast Cancer N/A Patients with metastatic breast cancer may respond well to treatment and me...
Show More Status
Active Not Recruiting
Location
Department of Oncology, Sahlgrenska University Hospital
Learn More & Join Trial
[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer PHASE1 The purpose of this trial is to estimate the recommended dose (RD) of \[177...
Show More Status
Active Not Recruiting
Location
UCLA Jonsson Comp Cancer Center
Learn More & Join Trial
To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer N/A This is a multi-center biomarkers study aiming to prospectively collect bio...
Show More Location
Hospital Santo Stefano
Learn More & Join Trial
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors PHASE1 This phase I trial tests the safety, side effects, and best dose of ZEN0036...
Show More Location
Keck Medicine of USC Koreatown
Learn More & Join Trial
Pyrotinib Combined With Trastuzumab,Dalpiciclib and Letrozole for HR+/HER2+ Breast Cancer PHASE2 In this single arm, open label, phase 2 trial, operable patients with stage...
Show More Location
Yantai Yuhuangding Hospital
Learn More & Join Trial
Palbociclib in Combination With Adjuvant Endocrine Therapy for Hormone Receptor Positive, HER2 Negative Invasive Breast Cancer PHASE2 This research study is evaluating a drug called Palbociclib in combination ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases PHASE1 This is a single arm study of abemaciclib and endocrine therapy with stereo...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) PHASE1 This is a study to investigate the potential clinical benefit of trilacicli...
Show More Location
Genesis Cancer Center
Learn More & Join Trial